AREV Life Sciences Global Corp. (AREVF)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Dec 18, 2025
AREV Life Sciences Global Market Cap
AREV Life Sciences Global has a market cap or net worth of $15.88 thousand as of January 21, 2026. Its market cap has decreased by -99.69% in one year.
Market Cap
15.88K
Enterprise Value
n/a
Revenue
5.33K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since April 30, 2019, AREV Life Sciences Global's market cap has decreased from 11.74M to 15.88K, a decrease of -99.86%. That is a compound annual growth rate of -63.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 15.88K | -99.38% |
| Dec 30, 2022 | 2.57M | -64.99% |
| Dec 31, 2021 | 7.34M | 67.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |